Skip to content
Aperlena
Free alerts

Poland - Pharmaceutical products - Purchase of panitumumab for the Chemotherapy Ward

Original Polska - Produkty farmaceutyczne - Zakup panitumumabu dla Oddziału Chemioterapii

Closed Contract notice

Key facts

Closed
Estimated value
€180,284 converted from PLN
Buyer
Szpital Grochowski im. dr med. Rafała Masztaka spółka z ograniczoną odpowiedzialnością
Where
Poland Warszawski stołeczny
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products 33652100 Antineoplastic agents
Original language
Polish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 3 weeks ago
Notice number
607067-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Deadline open for 15 days
  3. Awarded pending

Summary

Machine-generated summary

A Polish contracting authority is procuring successive deliveries of panitumumab (concentrate for solution for infusion, 20 mg/ml, in 5 ml and 20 ml vials) for its Chemotherapy Ward. Deliveries are split into partial orders, each to be fulfilled within 3 working days of the order being placed. Goods must have a minimum shelf life of 12 months from the delivery date. The buyer commits to using at least 75% of the gross contract value, depending on patient numbers and contracts with the National Health Fund. Partial bids and variant bids are not allowed. Full specifications are in attachment 2 to the request for quotations.

Description

Przedmiotem zamówienia są dostawy sukcesywne panitumumabu dla Oddziału Chemioterapii. Opis przedmiotu zamówienia znajduje się w załączniku nr 2 do SWZ. Wymagany termin realizacji dostaw częściowych: 3 dni robocze od złożenia zamówienia. Minimalny termin ważności asortymentu: 12 miesięcy od daty dostawy. Zamawiający zobowiązany będzie do wykorzystania minimum 75% wartości brutto udzielonego zamówienia. Wykorzystanie zależne będzie od liczby pacjentów zgłaszających się do Zamawiającego oraz od umów (kontraktów) z Narodowym Funduszem Zdrowia. Zamawiający nie dopuszcza możliwości składania ofert częściowych Zamawiający nie dopuszcza składania ofert wariantowych. Panitumumab (koncentrat do sporządzania roztworu do infuzji, 20mg/ml / opakowanie 5ml i 20ml)

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 weeks ago

View the official notice

More from this buyer

Full buyer profile

5 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,306,115
10,020 open across Europe right now 98% below sector average
Buyer track record on Aperlena
159 notices tracked · 75 awarded
€10,379,654 in awarded contracts

Never miss a tender like this

893 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language